嘉和生物药业（开曼）控股有限公司（06998）于2025年12月3日发布11月股份变动月报表。报告期为2025年11月，全月公司注册股本及已发行股份数量均无变化，股本保持稳定。
公司注册股本的法定数目与面值未发生变动，仍为10亿股、每股面值USD 0.00002，对应注册股本总额USD 20,000。报告期末已发行股份总数维持在528,291,792股，未出现新增发行、购回或注销情况，也无库藏股变动。
期权与激励方面，首次公开发售前购股权计划于当月有185,000股期权失效，其余期权数量保持不变。由于相关期权失效并未触发股份新增发行或回购，因此公司已发行股份总数继续维持稳定。
公告显示，公司确认遵守香港联交所《上市规则》及相关法律规定。该公告由执行董事兼首席财务官翁承毅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.